Injections, drops, or lozenges
When it becomes an approved option, retatrutide may be offered as a triple agonist weight loss treatment within a supervised program
Because of their effectiveness in treating obesity and diabetes, the WHO added GLP-1 therapies to its Essential Medicines List for managing type 2 diabetes in high-risk groups in September last year
A.DejongC
To view digital features for this article go to Introduction Obesity (defined as a body mass index [BMI] 30 kg/m 2 in adults [1]) is a major health concern in the USA [2] and is associated with multiple complications, including cardiovascular disease, type 2 diabetes, and osteoarthritis [3,4,5,6,7,8]
Don Rauf Author Don Rauf has been a freelance health writer for over 12 years and his writing has been featured in HealthDay, CBS News, WebMD, U.S